Company intelligence / Profile preview
Caldera Therapeutics
Emeryville, California, United Statescalderatx.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Caldera Therapeutics was a drug discovery company focused on developing small molecule modulators of ion channels, specifically the KCNQ family, for the treatment of epilepsy and chronic pain. The company reached the pre-clinical stage with several lead compounds but did not advance into clinical trials before dissolving around 2021.
- Therapeutic areas
- Neurology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Caldera Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Caldera Therapeutics.